CL.CN
CL.CN
CA22587M1068
CrescoLabsInc
Loading chart...

Company Profile

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

Related stocks

AQST
AQST • United States
Aquestive Therapeutics, Inc.
4.78 USD
599.95M USD 1Y -23.2%
EOLS
EOLS • United States
Evolus, Inc. Common Stock
7.73 USD
510.57M USD 1Y +25.6%
TLRY
TLRY • Canada
Tilray Brands, Inc.
3.54 USD
523.15M USD 1Y -79.1%
ESPR
ESPR • United States
Esperion Therapeutics, Inc.
3.18 USD
819.46M USD
CURA.TO
CURA.TO • United States
CURALEAF HOLDINGS INC
13.31 CAD
2.47B USD 1Y -4.4%
COLL
COLL • United States
Collegium Pharmaceutical, Inc.
22.09 USD
719.15M USD 1Y -33.3%
AMPH
AMPH • United States
Amphastar Pharmaceuticals, Inc.
26.62 USD
1.13B USD 1Y -0.7%
GTII.CN
GTII.CN • United States
GreenThumb
9.58 CAD
1.47B USD 1Y -21.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
101.5% p.a.
Max Drawdown (5Y)
-95.0%
Sharpe Ratio (5Y)
-0.40
Beta Factor
1.81
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 225%.
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.81 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (115.6%) is noticeably higher than the 5Y average (101.5%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (101.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -97.2% in the extended horizon.
ende